PE11399A1 - Combinacion de loratadina y un descongestionante para el tratamiento del asma - Google Patents

Combinacion de loratadina y un descongestionante para el tratamiento del asma

Info

Publication number
PE11399A1
PE11399A1 PE1997000968A PE00096897A PE11399A1 PE 11399 A1 PE11399 A1 PE 11399A1 PE 1997000968 A PE1997000968 A PE 1997000968A PE 00096897 A PE00096897 A PE 00096897A PE 11399 A1 PE11399 A1 PE 11399A1
Authority
PE
Peru
Prior art keywords
patient
asthma
loratadine
combination
treatment
Prior art date
Application number
PE1997000968A
Other languages
English (en)
Inventor
Alan G Harris
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of PE11399A1 publication Critical patent/PE11399A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE REFIERE AL USO COMBINADO DEL ANTIHISTAMINICO ANTISEDANTE LORATADINA Y DE UN DESCONGESTIONANTE PARA LA MANUFACTURA DE UN MEDICAMENTO PARA MEJORAR LA FUNCION PULMONAR DE UN PACIENTE QUE PADECE ASMA INCLUYENDO LA ADMINISTRACION AL PACIENTE DE UN TRATAMIENTO HABITUAL PARA LA RINITIS; EN DONDE DICHO DESCONGESTIVO SE SELECCIONA DE FENILPROPANOLAMINA, EFEDRINA, FENILEFRINA, PSEUDOEFEDRINA O UNA COMBINACION DE LAS MISMAS. SE MUESTRA QUE EL USO DE ANTIHISTAMINICOS QUE ERA CONTRAINDICADO SI EL PACIENTE TENIA ASMA, TENDRIA UN EFECTO BENEFICIOSO EN EL PACIENTE ASMATICO, INDEPENDIENTE SI EL PACIENTE PADECE O NO PADECE RINITIS
PE1997000968A 1996-10-31 1997-10-29 Combinacion de loratadina y un descongestionante para el tratamiento del asma PE11399A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73966996A 1996-10-31 1996-10-31

Publications (1)

Publication Number Publication Date
PE11399A1 true PE11399A1 (es) 1999-02-09

Family

ID=24973307

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1997000968A PE11399A1 (es) 1996-10-31 1997-10-29 Combinacion de loratadina y un descongestionante para el tratamiento del asma

Country Status (21)

Country Link
EP (1) EP0941091A1 (es)
JP (1) JP2000505104A (es)
KR (1) KR20000052922A (es)
CN (1) CN1235545A (es)
AR (1) AR008908A1 (es)
AU (1) AU731756B2 (es)
BR (1) BR9712705A (es)
CA (1) CA2268546A1 (es)
CO (1) CO4910128A1 (es)
CZ (1) CZ150999A3 (es)
HU (1) HUP9904075A3 (es)
ID (1) ID23431A (es)
IL (1) IL129662A0 (es)
NO (1) NO992062D0 (es)
NZ (1) NZ335078A (es)
PE (1) PE11399A1 (es)
PL (1) PL333056A1 (es)
SK (1) SK54599A3 (es)
TR (1) TR199901003T2 (es)
WO (1) WO1998018470A1 (es)
ZA (1) ZA979731B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999021556A1 (en) * 1997-10-29 1999-05-06 J-Med Pharmaceuticals, Inc. Antihistamine/decongestant regimens for treating rhinitis
US6132758A (en) 1998-06-01 2000-10-17 Schering Corporation Stabilized antihistamine syrup
IT1303671B1 (it) * 1998-07-28 2001-02-23 Nicox Sa Sali dell'acido nitrico con farmaci attivi nel trattamento dipatologie del sistema respiratorio
CO5271713A1 (es) * 1998-09-10 2003-04-30 Schering Corp Metodos y composiciones para tratar sinusitis, otitis media y otros desordenes relacionados usando antihistaminas
US6521254B2 (en) 1998-12-07 2003-02-18 J-Med Pharmaceuticals, Inc. Single-dose antihistamine/decongestant formulations for treating rhinitis
KR100505899B1 (ko) * 1999-02-23 2005-08-01 주식회사유한양행 로라타딘과 슈도에페드린을 함유한 캅셀제 조성물
ATE253354T1 (de) * 1999-02-23 2003-11-15 Yuhan Corp Kapseln mit loratadin und pseudoephedrin enthaltenden zusammensetzungen
AU3924500A (en) * 1999-03-29 2000-10-16 Schering Corporation Methods and compositions for treating allergic and related disorders using fluorinated descarboethoxyloratadine
WO2001045676A2 (en) * 1999-12-20 2001-06-28 Schering Corporation Extended release oral dosage composition
WO2001045668A2 (en) * 1999-12-20 2001-06-28 Schering Corporation Stable extended release oral dosage composition comprising pseudoephedrine and desloratadine
WO2001078782A1 (en) * 2000-04-14 2001-10-25 J-Med Pharmaceuticals, Inc. Single-dose antihistamine/decongestant formulations for treating rhinitis
PE20020055A1 (es) * 2000-05-25 2002-02-12 Schering Corp Formulaciones estables liquidas y solidas que comprenden una antihistamina no sedante y un descongestionante nasal
CN1518448A (zh) * 2001-06-20 2004-08-04 ���鹫˾ 用于治疗鼻充血和鼻塞的抗组胺剂
CA2612179C (en) 2005-06-17 2016-08-02 Aft Pharmaceuticals Limited A pharmaceutical composition comprising loratadine and its use to treat patients with upper respiratory mucosal congestion
BRPI0712532A2 (pt) * 2006-06-01 2013-04-02 Schering Plough Healthcare Prod Inc formulaÇÕes e composiÇÕes farmacÊuticas de fenilefrina para absorÇço colânica
NZ573174A (en) * 2006-06-01 2012-01-12 Msd Consumer Care Inc Sustained release pharmaceutical dosage form containing phenylephrine
KR101540191B1 (ko) * 2014-02-24 2015-07-28 성균관대학교산학협력단 로라타딘을 포함하는 항염증용 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1110397A (en) * 1964-10-02 1968-04-18 Mead Johnson & Co Ephedrine composition
US4990535A (en) * 1989-05-03 1991-02-05 Schering Corporation Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
US5407686A (en) * 1991-11-27 1995-04-18 Sidmak Laboratories, Inc. Sustained release composition for oral administration of active ingredient
US5314697A (en) * 1992-10-23 1994-05-24 Schering Corporation Stable extended release oral dosage composition comprising loratadine and pseudoephedrine
US5595997A (en) * 1994-12-30 1997-01-21 Sepracor Inc. Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine

Also Published As

Publication number Publication date
ZA979731B (en) 1998-04-29
NO992062L (no) 1999-04-29
JP2000505104A (ja) 2000-04-25
AR008908A1 (es) 2000-02-23
CN1235545A (zh) 1999-11-17
ID23431A (id) 2000-04-20
KR20000052922A (ko) 2000-08-25
SK54599A3 (en) 2000-08-14
HUP9904075A3 (en) 2002-02-28
TR199901003T2 (xx) 1999-07-21
BR9712705A (pt) 1999-10-26
CZ150999A3 (cs) 1999-10-13
CA2268546A1 (en) 1998-05-07
HUP9904075A2 (hu) 2000-05-28
WO1998018470A1 (en) 1998-05-07
NZ335078A (en) 2000-10-27
AU731756B2 (en) 2001-04-05
AU4995397A (en) 1998-05-22
IL129662A0 (en) 2000-02-29
CO4910128A1 (es) 2000-04-24
NO992062D0 (no) 1999-04-29
PL333056A1 (en) 1999-11-08
EP0941091A1 (en) 1999-09-15

Similar Documents

Publication Publication Date Title
PE11399A1 (es) Combinacion de loratadina y un descongestionante para el tratamiento del asma
BR0008276A (pt) Combinações de formoterol e propionato de fluticasona para asma
DE60117615D1 (de) Arzneimittelkombinationen (z.b. chlorpromazin und pentamidin) zur therapie von neoplastischen erkrankungen
HUP9700603A1 (hu) Gyógyászati készítmény véralvadási zavarok kezelésére
DE69738000D1 (de) Neue Arzneiformulierung enthaltend Budesonide
BR0307050A (pt) Composto, composição farmacêutica, métodos para o tratamento de doenças mediadas por prostaglandina d2, para o tratamento de congestão nasal, para o tratamento de asma alérgica, e para o tratamento de rinite alérgica, sal farmaceuticamente aceitável, e, uso de um composto ou sal
ATE329608T1 (de) Formulierungen von copolymer 1 (glatirameracetat) zur oralen, nasalen und pulmonalen verabreichung
AR016798A1 (es) Uso de una cepa de lactobacillus para la elaboracion de un medicamento
BRPI0108435B8 (pt) formulação e uso de entecavir de baixa dose
ES2166111T3 (es) Uso de tiagabina para el tratamiento de trastornos del sueño.
NO990522D0 (no) Anvendelse av <beta>-ark mimetika som protease- og kinaseinhibatorer av transkripsjonsfaktorer
DE69932510D1 (de) Vaskularisierungsinhibitoren
NO20004419L (no) Ny anvendelse
ATE291914T1 (de) Zolmitriptanhaltige arzneizusammensetzungen
ATE240717T1 (de) Wässrige formulierung zur nasalen verabreichung
RS49599B (sr) Upotreba inhibitora h+, k+-atp-aze i glukokortikoida i farmaceutska formulacija
DE60214527D1 (de) Verwendung von flumazenil bei der entwicklung eines arzneimittels zur behandlung von alkoholabhängigkeit
AR023687A1 (es) Una composicion para el tratamiento de desordenes de la retina externa y el uso de un antagonista de glutamato para la manufactura de un medicamento parael tratamiento de desordenes de la retina externa
ATE360428T1 (de) Analgetisches arzneimittel
ATE271852T1 (de) Verbesserte inhalationspräparate
HUP0204097A2 (hu) Guanozin-3',5'-monofoszfát-foszfodiészteráz inhibitorok alkalmazása diabetikus fekélyek kezelésére szolgáló készítmények előállítására
SE9902597D0 (sv) New use
EE04330B1 (et) Levosimendani transmukoossed koostised ja nende kasutamine ravimi valmistamiseks
HUP0204391A2 (en) The use of mirtazapine for the preparation of pharmaceutical composition suitable for the treatment of sleep disorders
BR0015781A (pt) Composição farmacêutica para tratamento de doenças associadas à diminuição de massa óssea

Legal Events

Date Code Title Description
FC Refusal